Population pharmacokinetics of melphalan in patients with multiple myeloma undergoing high dose therapy

Overview of attention for article published in British Journal of Clinical Pharmacology, February 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

news: 1 news outlet
patent: 7 patents

guideline: 1 clinical guideline source

Readers on

mendeley: 65 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

MELFLUFEN DOSAGE REGIMENS FOR CANCER

Application EP-3903777-A1

European Patent Office

03 Nov 2021

Injectable nitrogen mustard compositions comprising a cyclodextrin derivative and methods…

Grant US-11020363-B2

United States of America

01 Jun 2021

Injectable melphalan compositions comprising a cyclodextrin derivative and methods of…

Grant US-10940128-B2

United States of America

09 Mar 2021

MELFLUFEN DOSAGE REGIMENS FOR CANCER

Application EP-3750534-A1

European Patent Office

16 Dec 2020

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.